GLP-1s: Reshaping the Conversation

About this episode

This episode discusses the impact of GLP-1 receptor agonists on diabetes and obesity care with insights from experts.

GLP-1 receptor agonists are reshaping diabetes and obesity care, raising important questions about patient selection, side effect management, long-term outcomes, access, and the evolving role of diabetes care and education specialists (DCESs). In this episode of Diabetes Care Conversations, host Paola Acevedo, PharmD, CDCES, speaks with Diana Isaacs, PharmD, BC-ADM, CDCES, about what DCESs need to know about GLP-1 therapies, including their impact on treatment approaches, the importance of patient education, and emerging opportunities and challenges in care. Listen to more episodes of Diabetes Care Conversations at https://www.adces.org/practice/the-huddle-podcast Learn more about ADCES and the many benefits of membership at adces.org/join. The Diabetes Care Conversations Podcast is edited by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

People in this episode

Host: Paola Acevedo

Guest: Diana Isaacs

Topics covered

• diabetes care
• obesity care
• GLP-1 therapies
• patient education
• DCESs
• treatment approaches

Keywords

• GLP-1
• diabetes
• obesity
• patient education
• DCES
• treatment
• side effects

Mentioned in this episode

Organizations: Association of Diabetes Care & Education Specialists

Products: GLP-1 receptor agonists

More episodes of Diabetes Care Conversations

• It's Readiness All the Way Down · May 19, 2026 · 30 min
• ADCES26: Expertise in Action · May 5, 2026 · 12 min
• AI in Diabetes Care · April 21, 2026 · 28 min
• Becoming a CDCES · April 7, 2026 · 34 min
• Disordered Eating: A Hidden Challenge in Diabetes · March 24, 2026 · 30 min
• Integrating Diabetes Tech into Primary Care · March 10, 2026 · 20 min